The FTC’s latest interim staff report is part of the Commission’s ongoing study of the PBM industry. This report highlights several key insights gained from data and documents obtained from special ...
When considering the health care enforcement landscape in 2024 and where it might be headed in 2025, we would be remiss if we ...
HB1150 would ban the around 35 PBM-owned pharmacies in the state and prevent over 100 out-of-state PBM-owned pharmacies from ...
The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...
The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...
A bill filed Thursday (Jan. 16) in the Arkansas Legislature would prohibit pharmacy benefit managers and insurance companies from obtaining retail permits and operating pharmacies and mail order ...
The Arkansas Pharmacists Association is calling for public and legislative support for stronger regulation of Pharmacy ...
Prescription drug prices are rising, and a new report from the Federal Trade Commission (FTC) explains why. Pharmacy benefit ...
UnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
1don MSN
The Pharmaceutical Care Management Association, which represents PBM's, called the FTC report baseless and "without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback